178 related articles for article (PubMed ID: 35758193)
1. Microsatellite instability in rectal cancer: what does it mean? A study of two randomized trials and a systematic review of the literature.
Swets M; Graham Martinez C; van Vliet S; van Tilburg A; Gelderblom H; Marijnen CAM; van de Velde CJH; Nagtegaal ID
Histopathology; 2022 Sep; 81(3):352-362. PubMed ID: 35758193
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of the Microsatellite Instability Status in Patients With Stage II/III Rectal Cancer Following Upfront Surgery.
Oh CR; Kim JE; Kang J; Kim SY; Kim KP; Hong YS; Lim SB; Yu CS; Kim JC; Kim J; Jang SJ; Kim TW
Clin Colorectal Cancer; 2018 Dec; 17(4):e679-e685. PubMed ID: 30077598
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite Instability as a Prognostic Factor in Stage II Colon Cancer Patients, a Meta-Analysis of Published Literature.
Gkekas I; Novotny J; Pecen L; Strigård K; Palmqvist R; Gunnarsson U
Anticancer Res; 2017 Dec; 37(12):6563-6574. PubMed ID: 29187431
[TBL] [Abstract][Full Text] [Related]
4. Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis.
Wang B; Li F; Zhou X; Ma Y; Fu W
World J Surg Oncol; 2019 Oct; 17(1):169. PubMed ID: 31639018
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability and response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis.
O'Connell E; Reynolds IS; McNamara DA; Prehn JHM; Burke JP
Surg Oncol; 2020 Sep; 34():57-62. PubMed ID: 32891354
[TBL] [Abstract][Full Text] [Related]
6. The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer.
Hong SP; Min BS; Kim TI; Cheon JH; Kim NK; Kim H; Kim WH
Eur J Cancer; 2012 May; 48(8):1235-43. PubMed ID: 22071131
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Long-Term Outcomes of Microsatellite Instability Status in an Asian Cohort of Sporadic Colorectal Cancers.
Tan WJ; Hamzah JL; Acharyya S; Foo FJ; Lim KH; Tan IBH; Tang CL; Chew MH
J Gastrointest Cancer; 2018 Sep; 49(3):311-318. PubMed ID: 28550452
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite instability did not predict individual survival in sporadic stage II and III rectal cancer patients.
Meng WJ; Sun XF; Tian C; Wang L; Yu YY; Zhou B; Gu J; Xia QJ; Li Y; Wang R; Zheng XL; Zhou ZG
Oncology; 2007; 72(1-2):82-8. PubMed ID: 18004081
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of microsatellite instability in sporadic locally advanced rectal cancer following neoadjuvant radiotherapy.
Du C; Zhao J; Xue W; Dou F; Gu J
Histopathology; 2013 Apr; 62(5):723-30. PubMed ID: 23425253
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and predictive relevance of microsatellite instability in colorectal cancer.
Storojeva I; Boulay JL; Heinimann K; Ballabeni P; Terracciano L; Laffer U; Mild G; Herrmann R; Rochlitz C
Oncol Rep; 2005 Jul; 14(1):241-9. PubMed ID: 15944796
[TBL] [Abstract][Full Text] [Related]
11. Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.
Seppälä TT; Böhm JP; Friman M; Lahtinen L; Väyrynen VM; Liipo TK; Ristimäki AP; Kairaluoma MV; Kellokumpu IH; Kuopio TH; Mecklin JP
Br J Cancer; 2015 Jun; 112(12):1966-75. PubMed ID: 25973534
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite Instability and Survival in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis.
Petrelli F; Ghidini M; Cabiddu M; Pezzica E; Corti D; Turati L; Costanzo A; Varricchio A; Ghidini A; Barni S; Tomasello G
Anticancer Res; 2019 Dec; 39(12):6431-6441. PubMed ID: 31810907
[TBL] [Abstract][Full Text] [Related]
13. Association between microsatellite status and characteristics and outcomes of early-onset compared to late-onset rectal cancer.
Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Strassmann V; Wexner SD
Int J Colorectal Dis; 2024 Mar; 39(1):43. PubMed ID: 38538931
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database.
Uhlig J; Cecchini M; Sheth A; Stein S; Lacy J; Kim HS
J Natl Compr Canc Netw; 2021 Feb; 19(3):307-318. PubMed ID: 33530058
[TBL] [Abstract][Full Text] [Related]
15. Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis.
Toh JWT; Phan K; Reza F; Chapuis P; Spring KJ
Int J Colorectal Dis; 2021 Aug; 36(8):1573-1596. PubMed ID: 33604737
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma.
Colombino M; Cossu A; Manca A; Dedola MF; Giordano M; Scintu F; Curci A; Avallone A; Comella G; Amoruso M; Margari A; Bonomo GM; Castriota M; Tanda F; Palmieri G
Ann Oncol; 2002 Sep; 13(9):1447-53. PubMed ID: 12196371
[TBL] [Abstract][Full Text] [Related]
17. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K
J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive significance of microsatellite instability in stage II colorectal carcinoma: An 8-year study from a tertiary center in South India.
Paulose RR; Ail DA; Biradar S; Vasudevan A; Sundaram KR
Indian J Cancer; 2019; 56(4):302-308. PubMed ID: 31607697
[TBL] [Abstract][Full Text] [Related]
19. KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis.
Formica V; Sera F; Cremolini C; Riondino S; Morelli C; Arkenau HT; Roselli M
J Natl Cancer Inst; 2022 Apr; 114(4):517-527. PubMed ID: 34542636
[TBL] [Abstract][Full Text] [Related]
20. TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers.
Shima K; Morikawa T; Yamauchi M; Kuchiba A; Imamura Y; Liao X; Meyerhardt JA; Fuchs CS; Ogino S
PLoS One; 2011; 6(9):e25062. PubMed ID: 21949851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
